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Little is known about the relationship between lower-limb amputation (LLA) and subsequent changes in body weight. 
We conducted a retrospective cohort study using clinical and administrative databases to identify and follow weight 
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and transfemoral amputation [TFA], n = 96) and 3,790 men without amputation frequency-matched (5:1) on age, body 
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men with and without amputation. Weight gain in the 2 yr after amputation was significantly more in men with an 
amputation than without, and in men with a TTA or TFA (8%–9% increase) than in men with a PFA (3%–6% increase). 
Generally, percent weight gain peaked at 2 yr and was followed by some weight loss in the third year. These findings 
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Abstract — Little is known about the relationship between lower-limb amputation (LLA) and 
subsequent changes in body weight. We conducted a retrospective cohort study using clinical 
and administrative databases to identify and follow weight changes in 759 males with 
amputation (partial foot amputation [PFA], n = 396; transtibial amputation [TTA], n = 267; and 
transfemoral amputation [TFA], n = 96) and 3,790 men without amputation frequency-matched 
(5:1) on age, body mass index, diabetes, and calendar year from eight Department of Veterans 
Affairs medical care facilities in the Pacific Northwest. We estimated and compared longitudinal 
percent weight change from baseline up to 39 mo of follow-up in men with and without 
amputation. Weight gain in the 2 yr after amputation was significantly more in men with an 
amputation than without, and in men with a TTA or TFA (8%–9% increase) than in men with a 
PFA (3%–6% increase). Generally, percent weight gain peaked at 2 yr and was followed by 
some weight loss in the third year. These findings indicate that LLA is often followed by 
clinically important weight gain. Future studies are needed to better understand the reasons for 
weight gain and to identify intervention strategies to prevent excess weight gain and the 
deleterious consequences that may ensue. 
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INTRODUCTION 
An estimated 185,000 amputations are performed each year in the United States [1–3]. Excess 
body weight is a major concern for people with a lower-limb amputation (LLA) because it can 
have numerous deleterious consequences, including an increased risk of musculoskeletal pain, 
osteoarthritis, cardiovascular disease, falls and other injuries, impaired functional capacity, 
reduced prosthesis fit and function, and a diminished quality of life [4–8]. These consequences 
can in turn result in reduced activity levels and a cascade of events such as increased wheelchair 
use, a more sedentary lifestyle, greater healthcare utilization and costs, reduced ability to live 
independently, and increased burden on formal and informal caregivers [7–8]. 
A few older cross-sectional studies found that obesity was approximately two times more 
prevalent in persons with an LLA than in those without [9–10]. To our knowledge, only one 
longitudinal study has assessed weight change following LLA. This study included 87 
individuals who underwent a dysvascular LLA [11]. Compared with 6 wk after amputation, body 
mass index (BMI) had increased by 1.4 kg/m2 on average 12 mo postamputation, or about 4.5 kg 
(10 lb) for a person with a starting weight of 100 kg (220 lb) and height of 1.8 m (5 ft 10 in.), 
providing support for the hypothesis that amputation leads to excess weight gain. Nevertheless, 
this study was small, did not include a comparison group of persons without amputation, and 
examined outcomes only in the first year after an amputation. 
To better understand how an incident LLA may affect weight, observational studies are needed 
to describe typical weight trajectories to better understand the scope of the problem and 
ultimately to develop interventions to prevent unhealthy weight gain and improve health 
outcomes in this population. To this end, we conducted a retrospective cohort study with two 
primary aims: (1) to evaluate the relationship between incident amputation and body weight 
change in the 3 yr after an LLA relative to a demographically similar population without an 
amputation and (2) to examine the extent to which weight change varied by level of amputation 
(i.e., no amputation vs partial foot amputation [PFA], transtibial amputation [TTA], and 
transfemoral amputation [TFA]) and BMI prior to surgery. We hypothesized that weight gain 
would be greater among those with amputation than without, and among those with an 
amputation, those whose mobility was more impaired, operationalized as those with a more 
proximal amputation. We were uncertain of how preamputation BMI might affect weight gain. 
METHODS 
Population 
Data were obtained from the Department of Veterans Affairs (VA) Northwest Region database 
(Veterans Integrated Service Network [VISN] 20), which includes demographic characteristics 
and clinical and administrative medical record information on outpatient and inpatient encounter, 
vital sign, pharmacy, and laboratory data. VISN 20 is one of 21 VA networks and comprises 
eight medical centers (VA Puget Sound, Washington; Portland, Oregon; Spokane, Washington; 
Boise, Idaho; Walla Walla, Washington; Roseburg, Oregon; Anchorage, Alaska; and White 
Center, Oregon) and their community-based outpatient clinics. 
Cohort of Individuals with Incident Amputation 
We considered for inclusion male VISN 20 patients who had an incident toe, foot, or leg 
amputation (International Classification of Diseases–9th edition [ICD-9] surgical codes: 84.10–
84.17) between January 1, 1997, and December 31, 2008, and a plausible baseline weight 
("baseline" and "plausible" defined subsequently) and one or more follow-up weight(s) occurring 
between 2 wk and 39 mo (3.25 yr) after their baseline weight. We selected approximately 3 yr of 
follow-up to balance the desire for longer-term follow-up with the reality that for a relatively 
large fraction of patients, weights were not available 3 or more years after their amputation (e.g., 
due to death or lack of weight measures in the electronic medical record). Figure 1 presents 
exclusion criteria and numbers excluded for each reason. Briefly, we excluded women because 
they represented so few of all persons with an amputation. In order to limit our sample to a 
healthier population for whom a weight management intervention might be indicated, we 
excluded men who died or had a subsequent amputation within 18 mo of their index amputation. 
However, we included individuals who had two or more amputations within the initial 45 d 
postsurgical period who otherwise met the eligibility criteria noted previously. Their index 
amputation date was the date of their last amputation. Persons with amputation who had a 
subsequent major amputation 18 to 39 mo after their index amputation were censored at that time 
and no subsequent weights were included. Amputation etiology was inferred via diagnoses 
present at the time of the amputation. We created three mutually exclusive amputation groups 
based on the most proximal level of amputation: (1) PFA (ICD-9 84.11–84.12), (2) TTA (ICD-9 
84.13–84.16), and (3) TFA (ICD-9 84.17). 
Figure 1. 
Flow diagram of exclusions and study design of persons with amputation and frequency-matched 
nondisabled cohort. §For persons with amputation, baseline defined as median of weights measured 2–8 
wk after index amputation, or if not available, median of weights measured in 8 wk prior to amputation 
after subtracting predicted/estimated weight of limb loss (see Appendix, available online only). 
‡Disqualifying amputations were those that occurred at level higher than toe <18 mo after baseline (n = 
53). ICD-9 = International Classification of Diseases–9th edition, VA = Department of Veterans Affairs. 
Cohort of Individuals Without Amputation 
To determine what the typical weight trajectory might have been in the absence of an 
amputation, we constructed a comparison group of men without lower-limb loss (either prior to 
baseline or during follow-up) who were frequency matched (5:1) to persons with amputation 
based on (1) diabetes, (2) BMI (further explained subsequently), (3) age (in categories reflecting 
the age range of the persons with amputation), and (4) calendar year (see Figure 1 for more 
details). For matching purposes, BMI in persons with limb loss was based on their preamputation 
weight (Appendix, available online only). The reference date for persons without amputation 
was the first date that they had the matching factors and a weight record available. Persons 
without amputation who died <18 mo after their reference date or who did not have any weight 
measures 2 wk to 39 mo after baseline were not eligible for inclusion. 
Weight, Height, and Body Mass Index 
We used weights and heights obtained during inpatient and outpatient clinical encounters. 
Since we were not interested in assessing weight changes because of limb loss, in persons with 
an amputation baseline weight was the median of weights obtained 2 to 8 wk after their index 
amputation. We selected this time period because weights often fluctuate in the first 2 wk after 
an amputation due to changes in fluid balance. We divided follow-up time into 3 mo intervals 
and calculated the median recorded weight for each individual during each time interval for a 
maximum of 13 possible weight measurements per person during 39 mo of follow-up, or until 
the last day when data were available at the time this study was conducted (August 31, 2010), 
whichever was later, permitting a minimum of 20 mo of follow-up for all study participants. 
To address the potential problem of measurement and/or data entry errors, we used a multistep 
process to clean and select apparently valid weights and heights (Appendix). Among individuals 
with multiple height measures over time, the modal height was used to calculate BMI. 
Percent weight change, calculated as the difference between weight at time x and weight at 
baseline, divided by baseline weight × 100, was the primary outcome of interest. 
Other Covariates 
Demographic information (e.g., age, marital status, and race) was obtained from the VISN 20 
Data Warehouse. We recorded the service-connected disability (SCD) percentage as a measure 
of functional impairment as it relates to an individual’s military service. SCD percentage is 
associated with physical and mental health status and has been used as a proxy for 
socioeconomic status and disease severity [12]. Veterans with an SCD of 50 percent or higher 
qualify for healthcare and prescriptions without copayment. Comorbidity was assessed via 
diagnostic cost group (DCG) score. DCG is computed as a ratio of the person’s cost to the 
average cost in the entire Medicare population [13–14]. The DCG of the Medicare population 
average is calibrated to be 1; a DCG > 1 indicates greater costs than the average Medicare 
patient. The VA national average DCG is 0.7 based on fiscal year 2006 claims.1 
Statistical Methods 
Descriptive analyses include the presentation, by level of amputation, of percentages (for 
categorical variables) and medians and interquartile ranges (for continuous variables) for 
demographic, amputation-related and health-related characteristics. The distributions of 1, 2, and 
3 yr percent weight changes (relative to baseline) were summarized using the following 
categories: >5 percent weight loss, 5 percent weight loss to < 5 percent weight gain ("stable 
weight"), 5 to <10 percent weight gain, and ≥10 percent weight gain. To explore the shape of 
trajectories of percent weight change over time, we used nonparametric smoothing plots, overall 
and for different covariate subgroups. The "lowess" smoother uses locally weighted regression to 
fit a smooth curve representing average percent weight change as a function of time [15]. In 
parametric linear regression modeling of (continuous) percent weight change from baseline, we 
included time in months after the index amputation and time squared (to allow for nonlinear 
trends) as continuous variables. Because percent weight change was, by definition, zero for all 
subjects at baseline (time = 0), we fitted models without an intercept term. The effect of 
amputation status and matching variables (see Figure 1) was modeled by interactions with time. 
In addition, we included a three-way interaction of amputation level with BMI and time to allow 
for the possibility that the association between BMI and percent weight change varied by 
amputation level. Repeated measurements within person were accommodated using generalized 
estimating equations. 
We conducted a number of sensitivity analyses to evaluate the robustness of our findings. Since 
it was also reasonable to consider absolute (rather than percent) weight change as the outcome 
measure, we examined regression models with weight as the outcome measure. Because 
comorbidities and overall health status may differ between those with and without an amputation 
and may be associated with weight change, we conducted further analyses adjusting for disease 
burden as measured by DCG (in categories). We also conducted analyses limited to those who 
lived at least 39 mo after baseline. Finally, because of the imbalance in numbers of weights, we 
created a dichotomous variable (≥3 follow-up weight measures including ≥1 follow-up weight 
measure(s) from year 2 or 3 [more complete follow-up] vs not [less complete follow-up]) and 
analyzed results in those with more complete follow-up. Results from all sensitivity analyses 
were qualitatively similar to our main model results; consequently, we focus our presentation on 
our primary analyses. Statistical analyses were conducted using Stata 13.1 (StataCorp LP; 
College Station, Texas), and statistical significance was based on a p < 0.05. 
RESULTS 
A total of 759 men with incident amputations met the inclusion criteria (Figure 1). To form the 
comparison group of men without an amputation, we matched 5:1 on the factors described in the 
"Methods" section; we were unable to find a match for one person, leaving a total of 3,790 men. 
As expected based on our matching, the distribution of ages, BMI, reference years, and presence 
of a diabetes diagnosis was similar between persons with and without an amputation: 65 percent 
of individuals were between the ages of 55 and 74 yr, 73 percent had diabetes, and 40 percent 
were obese (Table 1). Compared with men without an amputation, a greater proportion of 
individuals with an amputation had a ≥50 percent SCD rating, had DCG > 1, and died or were 
censored during follow-up. Median number of follow-up measures was greater in persons with 
amputation than persons without amputation (7 vs 5), and among persons with amputation, was 
greater among those with a PFA than a TFA (medians of 8 and 5, respectively). However, the 
median number of measures was stable over time in persons without amputation (median of 2 
measures each year), while it decreased over time in persons with amputation (median of 4 in 
year 1, 2 in year 2, and 1 in year 3; data not presented), such that 35.7 percent of men with 
amputation (vs 19.9% of men without amputation) did not have a measure in year 3. When 
considering a composite measure of number of measures and duration of record, a similar 
proportion of those with and without an amputation (66% and 68%, respectively) had more 
complete follow-up, as defined in the "Methods" section (chi-square p = 0.26). 
Table 1.  
Characteristics of male veterans with and without lower-limb amputation. 
Characteristic Amputation 
Absent 
(N = 3,790) 
  
Amputation 
Present 
(N = 759) 
  Level of Amputation 
    
Partial 
Foot 
N = 396 
(52.2%) 
  Transtibial N = 267 (35.2%)   
Transfemoral 
N = 96 (12.6%) 
n %   n %   n %   n %   n % 
Age (yr)                             
<55 705 18.6   141 18.6   77 19.4   52 19.5   12 12.5 
55–64 1,470 38.8   294 38.7   152 38.4   110 41.2   32 33.3 
65–74 995 26.3   200 26.4   106 26.8   63 23.6   31 32.3 
75–89 620 16.4   124 16.3   61 15.4   42 15.7   21 21.9 
Reference Years                             
1997–2000 555 14.6   111 14.6   35 8.8   60 22.5   16 16.7 
2001–2002 670 17.7   134 17.7   69 17.4   48 18.0   17 17.7 
2003–2004 775 20.4   156 20.6   91 23.0   48 18.0   17 17.7 
2005–2006 880 23.2   176 23.2   94 23.7   55 20.6   27 28.1 
2007–2008 910 24.0   182 24.0   107 27.0   56 21.0   19 19.8 
Percent Service Connected*                             
<50 2,826 74.6   488 64.3   263 66.4   166 62.2   59 61.5 
≥50 964 25.4   271 35.7   133 33.6   101 37.8   37 38.5 
Diabetes Diagnosis                             
No 1,010 26.6   203 26.8   86 21.7   74 27.7   43 44.8 
Yes 2,780 73.4   556 73.3   310 78.3   193 72.3   53 55.2 
Diagnostic Cost Group 
Score† 
                            
<1 3,093 82.0   9 1.2   6 1.5   2 0.7   1 1.0 
1–1.9 563 14.9   104 13.7   69 17.4   26 9.7   9 9.4 
2–2.9 84 2.2   260 34.3   146 36.9   87 32.6   27 28.1 
≥3 34 0.9   386 50.9   175 44.2   152 56.9   59 61.5 
Time until Censoring or 
Death‡ 
                            
Censored 18–30 mo post 
baseline 
456 12.0   171 22.5   89 22.5   54 20.2   28 29.2 
Censored 30–39 mo post 
baseline 
409 10.8   119 15.7   64 16.2   38 14.2   17 17.7 
Amputation-free survival 
≥39 mo 
2,925 77.2   469 61.8   243 61.4   175 65.5   51 53.1 
Body Mass Index (kg/m2)§                             
<25 935 24.7   187 24.6   93 23.5   60 22.5   34 35.4 
25.0–29.9 1,325 35.0   265 34.9   139 35.1   91 34.1   35 36.5 
≥30 1,530 40.4   307 40.4   164 41.4   116 43.4   27 28.1 
No Follow-Up Weight 
Measures 
Available In Given Time 
Interval 
                            
Year 1 290 7.7   30 4.0   11 2.8   11 4.1   8 8.3 
Year 2 607 16.0   116 15.3   50 12.6   43 16.1   23 24.0 
Year 3 754 19.9   271 35.7   131 33.1   93 34.8   47 49.0 
Note: Matching variables were age, reference year (in categories shown), diabetes, and preamputation body 
mass index (in categories shown). 
*<50% service connected includes those "not service connected." 
†Diagnostic cost group score represents prospective risk score based on expenditures in reference year. Risk score of Medicare population average is calibrated to 
be 1. 
‡Individuals were censored at time of death, subsequent amputation, or August 31, 2010, whichever came 
first. 
§Body mass index is based on measured weight and height prior to amputation in persons with amputation. 
When preamputation weight was not available, weight of amputated limb was estimated. See "Methods" 
section for more information. 
The most frequent diagnoses present at the time of amputation were diabetes (72.1%), peripheral 
vascular disease (64.2%), and local significant infection (60.2%). Only 12.9 percent had a 
diagnosis code indicating trauma, and 0.6 percent had a code indicative of a lower-limb cancer. 
Diabetes was less common and peripheral vascular disease diagnosis was more common in men 
with a TFA (55.2% and 74.0%, respectively) than men with a more distal amputation (data not 
presented). 
In unadjusted analyses, mean percent weight change and the proportion of men gaining 
≥10 percent of their baseline weight approximately 1, 2, and 3 yr after baseline was greater in 
men with amputation versus without, and among men with an amputation, it was greater in those 
with a TTA and TFA than a PFA (Tables 2 and 3). Over 45 percent of men who had a TTA or a 
TFA gained ≥10 percent of their body weight by the end of the second year of follow-up, 
compared with 9.2 percent of men without amputation and 22.7 percent of men with a PFA 
(Table 3). By the end of the third year of follow-up, the percentage of individuals who gained 
≥10 percent of body weight was similar to those at the end of the second year, but there was a 
slight increase in the proportion of individuals who lost ≥5 percent of their body weight since 
baseline (18.5% among men without amputation and 19.7%, 13.0%, and 22.5% among men with 
a PFA, TTA, and TFA, respectively). 
Table 2.  
Unadjusted (observed) percentage weight changes from baseline. 
Time Window* 
No Amputation  
  Level of Amputation 
  Partial Foot   Transtibial   Transfemoral 
M IQR   M IQR   M IQR   M IQR 
~1 yr 0.5 –2.6, 4.0   3.0 –2.3, 8.3   7.7 0.2, 15.0   7.7 0.0, 16.0 
~2 yr 0.5 –3.2, 4.6   3.2 –2.2, 8.9   8.4 0.1, 16.0   9.8 1.2, 17.0 
~3 yr 0.5 –3.6, 4.7   2.2 –2.9, 9.5   9.7 –0.1, 18.0   9.7 0.6, 17.0 
Note: See Table 1 for N at each time interval. 
*Time windows for ~1, ~2, and~3 yr: 10–18 mo, 22–30 mo, and 31–39 mo, respectively. 
IQR = interquartile range, M = median. 
Table 3.  
Unadjusted (observed) categories of percentage weight changes. 
Change from Baseline* 
No Amputation  
  Level of Amputation 
  Partial Foot   Transtibial  Transfemoral 
n %   n %   n %   n % 
~1 yr                       
>5% Weight Loss 405 13.0   51 14.5   27 12.1   11 16.9 
Stable Weight 2,105 67.4   163 46.4   64 28.7   16 24.6 
5 to <10% Weight Gain 400 12.8   72 20.5   43 19.3   10 15.4 
≥10% Weight Gain 215 6.9   65 18.5   89 39.9   28 43.1 
~2 yr                       
>5% Weight Loss 489 16.9   47 15.7   24 12.4   9 13.8 
Stable Weight 1,743 60.3   129 43.1   51 26.3   14 21.5 
5 to <10% Weight Gain 392 13.6   55 18.4   30 15.5   11 16.9 
≥10% Weight Gain 266 9.2   68 22.7   89 45.9   31 47.7 
~3 yr                       
>5% Weight Loss 513 18.5   45 19.7   21 13.0   9 22.5 
Stable Weight 1,600 57.8   94 41.2   35 21.7   4 10.0- 
5 to <10% Weight Gain 369 13.3   36 15.8   25 15.5   8 20.0 
≥10% Weight Gain 288 10.4   53 23.2   80 49.7   19 47.5 
*Time windows for ~1, ~2, and~3 yr: 10–18 mo, 22–30 mo, and 31–39 
mo, respectively. 
 
As shown in Figure 2, in the first 2 yr of follow-up, mean estimated percentage weight gain in men with 
amputation was considerably greater than in men without amputation. Weight gain peaked in the 
second year, followed by weight loss from the peak but not a return to baseline weight, except in men 
without amputation. In men with an amputation, at each time point, mean percent weight change was 
greater among men with a TTA and TFA than men with a PFA. Percent weight changes in men with a TTA 
and TFA were not statistically significant different from each other at any time point. 
 
 
 
Figure 2. 
Estimated mean percent weight change from baseline by amputation group. Predicted percent weight change estimates are based 
on linear regression model that used generalized estimating equations to account for within-person correlation. Model included 
parameters for time and time squared and interactions of time and time squared with age (<55, 55-64, 65-74, ≥ 75 yr), diabetes, 
reference year, amputation level (none, partial foot amputation [PFA], transtibial amputation [TTA], transfemoral amputation 
[TFA]), body mass index (BMI) (continuous, centered at the mean of 30) and BMI × amputation level. Estimates presented are 
for reference years 2001–2002, 55–64 yr, with diabetes and BMI = 30. 
Table 4 presents mean percent weight change estimates and 95 percent confidence intervals from the 
multivariable model at 12, 24, and 36 mo follow-up, stratified by baseline BMI (25, 30, and 35 kg/m2). 
For men without amputation and men with a PFA and TTA, mean percent weight change decreased with 
increasing preamputation BMI (though the differences were not statistically significant for men with a 
TTA at 3 yr follow-up). For men with a TFA, percent weight change was similar across preamputation 
BMI levels. 
Table 4.  
Predicted percent weight changes from baseline at 12, 24, and 36 mo in persons with and 
without a lower-limb amputation with body mass index (BMI) = 25, 30, and 35 kg/m2. 
BMI (kg/m2) 
Percent Weight Change 
12 mo   24 mo   36 mo 
Estimate 95% CI   Estimate 
95% 
CI   Estimate 
95% 
CI 
BMI = 25               
No Amputation +2.2 1.5 
to 
2.9 
  +3.0 2.1 
to 
3.9 
  +2.4 1.4 
to 
3.4 
Partial Foot Amputation +4.4 3.2 
to 
5.6 
  +6.0 4.4 
to 
7.6 
  +4.7 2.7 
to 
6.6 
Transtibial Amputation +8.1 6.5 
to 
9.8 
  +11.4 9.3 
to 
13.5 
  +9.8 7.6 
to 
12.1 
Transfemoral Amputation +9.3 6.4 
to 
12.2 
  +11.9 8.4 
to 
15.4 
  +7.8 2.8 
to 
12.8 
BMI = 30                 
No Amputation +1.3 0.7 
to 
1.8 
  +1.6 0.8 
to 
2.4 
  +1.0 0.0 
to 
1.9 
Partial Foot Amputation +3.4 2.5 
to 
4.4 
  +4.4 3.1 
to 
5.7 
  +3.0 1.4 
to 
4.6 
Transtibial Amputation +6.9 5.6 
to 
8.2 
  +9.9 8.2 
to 
11.6 
  +9.0 7.1 
to 
11.0 
Transfemoral Amputation +8.7 6.1 
to 
11.4 
  +12.2 8.8 
to 
15.6 
  +10.2 5.7 
to 
14.9 
BMI = 35                 
No Amputation +0.4 –0.2 
to 
0.9 
 +0.2 –0.5 
to 
0.9 
 –0.5 –1.5 
to 
0.5 
Partial Foot Amputation +2.4 1.4 
to 
3.5 
  +2.9 1.4 
to 
4.4 
  +1.3 –0.5 
to 
3.2 
Transtibial Amputation +5.7 4.3 
to 
7.1 
  +8.4 6.5 
to 
10.4 
  +8.2 6.0 
to 
10.5 
Transfemoral Amputation +8.2 4.7 
to 
11.7 
  +12.4 7.6 
to 
17.3 
  +12.8 5.6 
to 
19.9 
Note: Predicted percent weight change estimates are based on linear regression model that used 
generalized estimating equations to account for within-person correlation. Model included 
parameters for time and time squared, interactions of time and time squared with age (<55, 55–
64, 65–74, ≥ 75 yr), diabetes, reference year, amputation level (none, partial foot, transtibial, 
transfemoral), BMI (continuous, centered at the mean of 30), and BMI × amputation level. 
Estimates presented are for reference years 2001–2002, 55–64 yr, and with diabetes. 
CI = confidence interval. 
 
DISCUSSION 
Excess weight gain can have both immediate and long-term adverse consequences in people with 
LLA. Data from our study indicate that weight gain in the 2 yr after amputation is substantial. 
Specifically, men with more proximal amputations (e.g., TTA and TFA) gained more weight 
after amputation, approximately 8 to 9 percent body weight (7–8 kg [16–18 lb], assuming a 
starting weight of 90 kg [200 lb]) than men with a more distal amputation (approximately 3%–
6% or 3–4 kg [6–8 lb]). Furthermore, weight gain in men with a PFA (and all other amputation 
groups) was significantly more than in a demographically similar population of men without an 
amputation. Generally, weight gain peaked at around 2 yr, followed by weight loss. However, 
estimates in the third year were relatively imprecise because of missing data. For men with PFA 
and TTA (but not men with a TFA), percent weight gain was inversely proportional to baseline 
BMI. 
Although our data were inadequate for understanding the mechanisms behind the weight 
changes, there are a number of plausible explanations. Weight gain in the first 2 yr after 
amputation may have occurred because of decreased activity and/or overeating. Other 
investigators have found the most popular leisure time activities among people with LLA were 
sedentary (e.g., watching television, going to restaurants, and playing cards) even in individuals 
who were active before their amputation [16]. The wound healing process may take weeks or 
months, and individuals may be unable or unmotivated to be physically active at this time. 
Additionally, it may take up to 12 mo to obtain a properly fitting prosthesis, and physical activity 
tends to decrease during this time [17]. Barriers related to prosthesis fitting are likely more 
limiting for people with a TTA and TFA than a PFA and may explain the differential weight gain 
by amputation level. Comorbid depression, which is highly prevalent in this population [18–19], 
may also contribute to inactivity and overeating. Our prior work suggested that high BMI and 
weight gain are associated with impaired mobility [11], resulting in lower levels of physical 
activity. The inverse association between preamputation BMI and relative weight gain may be 
because those with a lower BMI preamputation may have been more active and decreased their 
activity more postamputation than those with a higher BMI, though future studies are needed to 
replicate and better understand this finding. The slowing of weight gain and possible weight loss 
in the third year may be explained by improvement in depressive symptoms [19] as individuals 
come to accept their amputation and become more adept and comfortable with ambulating and 
increase their physical activity. An alternative explanation for the weight loss is illness; though 
we constructed our study to include a healthier population, mortality is high in this population. 
We are aware of only one other study that investigated weight change following amputation [11]. 
In that study, mean weight gain in 87 people with a dysvascular major amputation was 6 lb over 
12 mo, which is somewhat less than that observed in this study and may reflect different 
inclusion criteria [11]. Nevertheless, the two studies are in agreement regarding the direction of 
weight change. Our study builds on the prior literature by documenting, in a relatively 
heterogeneous population that included amputations from multiple etiologies, how percent 
weight change varies by amputation level and preamputation BMI and provides comparative data 
in demographically similar men without an amputation. Together, these studies highlight the 
magnitude of this problem, reinforce the detrimental consequences of excess weight gain, and 
indicate a need for further research to identify effective weight management interventions. 
While use of medical record data allowed assessment of weight change on a relatively large, population-
based sample of VA users, it also led to a number of limitations. The weight data were obtained from 
routine clinical practice and not collected at predefined time intervals using standardized data collection 
procedures as would be specified in a study protocol. To eliminate weights that might introduce 
statistical noise and reduce our ability to detect patterns, we carefully cleaned the data before selecting 
median values. However, when individuals had few weights, it was more difficult to identify and remove 
plausible but potentially erroneous weights. Additionally, the availability of recorded weights varied in 
this population; some men had weight data in year 1 only, while others had measurements in all years. 
While our modeling technique allowed us to take greatest advantage of the data that were available, 
substantial missing data in the third year of follow-up resulted in less precision in these estimates, and 
this was particularly evident in men with a TFA. In sensitivity analyses comparing weight changes in 
those with more versus fewer weight measures, the prevailing trends of overall weight gain were 
apparent, though less marked. The attenuation of weight gain may be because approximately 
13 percent of persons with amputation died in the 18 to 39 mo after baseline (see Appendix, Table 1), 
and death is typically preceded by weight loss. Thus, our findings are likely more reflective of the 
healthier population of people with lower-limb loss. Furthermore, it was not possible to determine 
whether weight was measured with the individual wearing his prosthesis, how much that prosthesis 
weighed, and if prosthesis use changed over time. However, the mean weight gain observed at 2 yr in 
persons with a TTA and TFA was on average more than the potential error introduced by a prosthesis 
(which weighs approximately 3 and 5 kg, respectively, for a transtibial and transfemoral prosthesis) and 
cannot explain any of the weight gain observed in men with a PFA. Future longitudinal studies 
employing standardized assessment of weight, body composition measures, physical activity, and 
comorbidities could eliminate the errors noted here and would also be helpful in expanding our 
understanding of the predictors of body weight changes and may help to identify targets for 
intervention. Finally, though we constructed a comparison cohort of individuals who were very similar to 
the persons with amputation in terms of age, reference year, BMI, and diabetes, there were large 
differences in their morbidity, as assessed by DCG scores and the percent that died during follow-up. 
However, results from sensitivity analyses adjusting for DCG were similar. 
CONCLUSIONS 
It is well documented that obesity is related to many health conditions to which this sample is 
susceptible, including additional amputations, heart disease, and stroke [20]. Thus, using the time 
of amputation to promote improved lifestyle habits and weight loss could result in a range of 
physical, mental, and social benefits. Our preliminary findings suggest that LLA is often 
followed by clinically important weight gain, but future studies will need to verify our results 
using standardized measures of BMI, larger samples, and longer follow-up periods. It would also 
be informative to measure lifestyle habits such as physical activity, mode of ambulation (e.g., 
prosthesis, crutches, manual wheelchair, motorized wheelchair), sedentary behaviors, dietary 
behaviors, and health status changes in order to accurately identify the likely causal factors. 
Finally, future studies are also needed to determine whether promoting weight loss following 
amputation is feasible and can result in health and quality of life benefits. 
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